D
Daigo Hashimoto
Researcher at Hokkaido University
Publications - 130
Citations - 11320
Daigo Hashimoto is an academic researcher from Hokkaido University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 33, co-authored 111 publications receiving 9351 citations. Previous affiliations of Daigo Hashimoto include Japanese Foundation for Cancer Research & Kyoto University.
Papers
More filters
Journal ArticleDOI
Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes
Daigo Hashimoto,Andrew Chow,Andrew Chow,Clara Noizat,Clara Noizat,Pearline Teo,Mary Beth Beasley,Marylene Leboeuf,Christian Becker,Peter See,Jeremy Price,Daniel Lucas,Melanie Greter,Melanie Greter,Arthur Mortha,Scott W. Boyer,E. Camilla Forsberg,Masato Tanaka,Nico van Rooijen,Adolfo García-Sastre,E. Richard Stanley,Florent Ginhoux,Paul S. Frenette,Miriam Merad +23 more
TL;DR: Results indicate that tissue-resident macrophages and circulating monocytes should be classified as mononuclear phagocyte lineages that are independently maintained in the steady state.
Journal ArticleDOI
Origin of the lamina propria dendritic cell network.
Milena Bogunovic,Florent Ginhoux,Julie Helft,Limin Shang,Daigo Hashimoto,Melanie Greter,Kang Liu,Claudia Jakubzick,Molly A. Ingersoll,Marylene Leboeuf,E. Richard Stanley,Michel C. Nussenzweig,Sergio A. Lira,Gwendalyn J. Randolph,Miriam Merad +14 more
TL;DR: It is shown that monocytes gave rise exclusively to CD103(-)CX(3)CR1(+) lamina propria DCs under the control of macrophage-colony-stimulating factor receptor (M-CSFR) and Fms-like thyrosine kinase 3 (Flt3) ligands.
Journal ArticleDOI
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Hélène Salmon,Juliana Idoyaga,Adeeb Rahman,Marylene Leboeuf,Romain Remark,Stefan Jordan,Maria Casanova-Acebes,Makhzuna Khudoynazarova,Judith Agudo,Navpreet Tung,Svetoslav Chakarov,Christina Rivera,Brandon Hogstad,Marcus Bosenberg,Daigo Hashimoto,Sacha Gnjatic,Nina Bhardwaj,Anna Karolina Palucka,Brian D. Brown,Joshua Brody,Florent Ginhoux,Miriam Merad +21 more
TL;DR: The paucity of activated CD103(+) DCs in tumors limits checkpoint-blockade efficacy and combined FLT3L and poly I:C therapy can enhance tumor responses to checkpoint and BRAF blockade.
Journal ArticleDOI
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow,Daniel Lucas,Daniel Lucas,Andrés Hidalgo,Andrés Hidalgo,Simón Méndez-Ferrer,Simón Méndez-Ferrer,Daigo Hashimoto,Christoph Scheiermann,Christoph Scheiermann,Michela Battista,Marylene Leboeuf,Colette Prophete,Colette Prophete,Nico van Rooijen,Masato Tanaka,Miriam Merad,Paul S. Frenette,Paul S. Frenette +18 more
TL;DR: Results highlight two antagonistic, tightly balanced pathways that regulate maintenance of HSCs/progenitors in the niche during homeostasis, in which MΦ cross talk with the Nestin+ niche cell promotes retention, and in contrast, SNS signals enhance egress.
Journal ArticleDOI
The origin and development of nonlymphoid tissue CD103+ DCs
Florent Ginhoux,Kang Liu,Julie Helft,Milena Bogunovic,Melanie Greter,Daigo Hashimoto,Jeremy Price,Na Yin,Jonathan S. Bromberg,Sergio A. Lira,E. Richard Stanley,Michel C. Nussenzweig,Miriam Merad +12 more
TL;DR: It is shown that two populations of CD11c+MHCII+ cells separated on the basis of CD103 and CD11b expression coexist in most nonlymphoid tissues with the exception of the lamina propria.